Barclays Starts Zimmer Biomet (ZBH) at Equalweight
Barclays analyst Matt Miksic initiates coverage on Zimmer Biomet (NYSE: ZBH) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

